Cary Street Partners Financial LLC Biogen Inc. Transaction History
Cary Street Partners Financial LLC
- $3.07 Trillion
- Q4 2024
A detailed history of Cary Street Partners Financial LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cary Street Partners Financial LLC holds 1,742 shares of BIIB stock, worth $238,793. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,742Holding current value
$238,793% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
995Shares Held
131MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.3 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.2 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.99 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.01 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$676 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $19.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...